The Healthon Weight Loss Program offers two highly effective GLP-1 medications: Semaglutide (Generic Ozempic/Wegovy): A GLP-1 receptor agonist, FDA-approved for weight management and type 2 diabetes
The Company has two proprietary commercial products, Hylenex and XYOSTED , partnered commercial products, and ongoing development programs with Teva Pharmaceuticals and McDermott Laboratories Limited, an affiliate of Viatris Inc
This corresponds to an increase of ~225% of plasma glucagon when corrected for the change in glucose concentration
The rate and magnitude of glucose elevation depend on baseline diabetes severity, duration of disease, beta-cell function, and concurrent medications
CrossRef Postbiotics from Lacticaseibacillus rhamnosus IOB820 Combat Obesity in HFD Mice by Modulating Gut Microbiota and Enhancing SCFA Production Xiaomin Feng, Hanlu Li, Jianxia Tian, Xuemei Han, Wu Liang, Feiliang Zhong, Xuegang Luo Nutrients.2025
Acknowledgements We express our gratitude to all the families who participated in the study